open
Q-LINE BIOQ-Line Biotech IPO
Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range.
Advertisement (Slot: header)
Price Band
🟢
Lot Size
0 Shares
Issue Size
Approx ₹214.48 Crores, 62,53,200 Equity Shares
Current GMP
₹129 (May 29)
IPO Timeline
Open DateMay 29, 2026
Close DateMay 29, 2026
Basis of AllotmentTBA
Listing DateMay 19, 2026
Subscription Status
Overall subscription
Financial Information
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹184.81 | ₹154.97 | ₹32.10 | ₹251.58 |
| 2024 | ₹206.45 | ₹175.85 | ₹34.44 | ₹339.25 |
| 2025 | ₹322.58 | ₹261.43 | ₹28.13 | ₹455.49 |
| Dec 2025 | ₹236.50 | ₹186.96 | ₹38.69 | ₹561.34 |
Promoters
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 1,70,74,999 | 96.77% |
| Promoter Holding Post Issue | 2,33,28,199 | -% |
Objects of the Issue
- Hem Securities Ltd.
- Share India Capital Services Pvt. Ltd.